KSE
Articles
- Page Path
- HOME > Epidemiol Health > Volume 47; 2025 > Article
- Correspondence Authors’ Reply: Safety of combination therapy of azilsartan medoxomil and amlodipine: a population-based cohort study
-
Hyesung Lee1
, Bin Hong2
, Chris Tzu-Ting Su3
, Sungho Bea4
, Han Eol Jeong5
, Kyungyeon Jung2
, Michael Chun-Yuan Cheng3
, Zoe Chi-Jui Chang3
, Edward Chia-Cheng Lai3
, Jongyoung Lee6
-
Epidemiol Health 2025;47e2025054-0
DOI: https://doi.org/10.4178/epih.e2025054
Published online: September 20, 2025
1Department of Medical Informatics, Kangwon National University College of Medicine, Chuncheon, Korea
2School of Pharmacy, Sungkyunkwan University, Suwon, Korea
3School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
4Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA
5DSC Investment, Seoul, Korea
6Division of Cardiology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea
2School of Pharmacy, Sungkyunkwan University, Suwon, Korea
3School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
4Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA
5DSC Investment, Seoul, Korea
6Division of Cardiology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea
-
Corresponding author:
Hyesung Lee,
Email: hs.lee@kangwon.ac.kr
Received: 18 August 2025 • Accepted: 22 August 2025
- 177 Views
- 13 Download
- 0 Crossref
- 0 Scopus
Cite
